Anika Therapeutics
ANIK
#9072
Rank
ยฃ0.13 B
Marketcap
ยฃ10.14
Share price
-2.50%
Change (1 day)
39.18%
Change (1 year)
Categories

EPS for Anika Therapeutics (ANIK)

EPS in 2026 (TTM): -ยฃ0.19

According to Anika Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ0.20. In 2025 the company made an earnings per share (EPS) of -ยฃ0.58 an increase over its 2024 EPS that were of -ยฃ2.94.

EPS history for Anika Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.19-66.43%
2025-ยฃ0.58-80.26%
2024-ยฃ2.94-31.86%
2023-ยฃ4.32448.54%
2022-ยฃ0.79-455.17%
2021ยฃ0.22-115.68%
2020-ยฃ1.41-195.85%
2019ยฃ1.4748.46%
2018ยฃ0.99-40.37%
2017ยฃ1.67-1.8%
2016ยฃ1.707.77%
2015ยฃ1.57-21.37%
2014ยฃ2.0074.67%
2013ยฃ1.1570.45%
2012ยฃ0.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.10-2,669.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
ยฃ3.12-1,669.23%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Stryker Corporation
SYK
ยฃ7.22-3,734.62%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
ยฃ2.69-1,453.85%๐Ÿ‡บ๐Ÿ‡ธ USA